Kyle Smith

Resolving medulloblastoma cellular architecture by single-cell genomics

Volker Hovestadt, Kyle Smith, Laure Bihannic et al. · Nature · 2019 · 412 citations · Full text

Tumor Heterogeneity, Medicine, Single Cell Sequencing +5

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar, Giles Robinson, Kyle Smith et al. · Journal of Clinical Oncology · 2021 · 217 citations · Full text

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

Giles Robinson, Vasilisa A. Rudneva, Ivo Buchhalter et al. · The Lancet Oncology · 2018 · 216 citations · Full text

Neuro-oncology, Oncology, Risk-adapted Therapy +7

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Jeff M. Michalski, Anna J. Janss, L. Gilbert Vezina et al. · Journal of Clinical Oncology · 2021 · 181 citations · Full text

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

Sebastian M. Waszak, Giles Robinson, Brian Gudenas et al. · Nature · 2020 · 166 citations · Full text

Developmental Biology, Somatic Variant, Developmental Genetics +6